For patients with a KIR-ligand missing genotype (n = 122 or 121), there was no significant improvement in PFS, OR, or tumor shrinkage as compared to patients with KIR-ligand present (n = 78 or 76) (Fig. 1A–C). The gene discussed is KIR3DL1; the disease is neoplasm.